All articles tagged with #sunrun
Stocks experienced mixed movements with notable gains in Dayforce, UnitedHealth, Novo Nordisk, GoodRx, and Sunrun, driven by acquisition talks, FDA approvals, and strategic partnerships, while other stocks like Intel and solar companies also saw significant activity ahead of upcoming earnings reports and policy speeches.
Stocks declined following Trump's tariffs and higher-than-expected jobless claims, with notable movements including Eli Lilly dropping 14% after weight-loss pill data, Fortinet falling 25% despite strong earnings, and Sunrun soaring 32% on robust earnings. Other significant changes involved AppLovin, Airbnb, Peloton, Vistra, DraftKings, Duolingo, Lyft, and Zillow, reflecting mixed earnings results and outlooks amid economic uncertainties.
Sunrun Inc's stock plummeted by 28% following Donald Trump's election as U.S. president, as his administration is expected to reverse green energy policies that have benefited the company. Trump's plans to repeal green energy tax credits and impose tariffs on imports could significantly impact Sunrun's growth and profitability by increasing costs and reducing demand for solar installations. The potential rollback of federal support for renewable energy poses a major challenge for Sunrun and the broader solar industry.
Analysts have made significant calls on several major companies, including Nvidia, Amazon, SolarEdge, Sunrun, IBM, Crocs, Meta, and Disney. The calls likely involve recommendations or assessments of these companies' stocks or business prospects, but specific details are not provided in the article.
Jim Cramer advises against investing in Blackstone due to lack of transparency, recommends avoiding solar stocks like Sunrun, prefers PSA over Extra Space, suggests caution with Fifth Third ahead of regional banks' earnings reports, expresses concerns about Dominion Energy's management and dividends, likes FMC as an agricultural play, advises against BP in favor of independent Permian companies, and warns against investing in Paramount due to its troubled balance sheet.
Intel's shares rose 2.5% as the chipmaker announced plans to operate its programmable chip unit as a standalone business and conduct an IPO within the next few years. Fluor saw a 2.4% increase in shares after receiving an upgrade to buy from UBS, citing progress on legacy projects. Apple's stock dropped 0.9% after KeyBanc downgraded its rating due to high valuation and expected soft growth in the US. Sunrun and Sunnova shares fell 3% and 2.8% respectively after being downgraded by Truist Securities, citing potential impact from higher interest rates. Moderna's stock rose slightly after announcing positive interim results for its investigational combination vaccine against influenza and Covid.
Unusual options activity has been observed in Sunrun (NASDAQ: RUN), with a significant bearish sentiment detected. A whale investor has made several trades, including puts and calls, targeting a price range of $10.0 to $40.0 for Sunrun over the last three months. The volume and open interest for Sunrun options trades indicate a mean open interest of 2708.11 and a total volume of 4,618.00. The stock price of RUN is currently down 2.31% at $10.98, with RSI indicators suggesting it may be oversold. Analysts from JP Morgan, Guggenheim, and Susquehanna have maintained their ratings and price targets for Sunrun. Options trading carries higher risk but also higher profit potential.
Qualcomm, PayPal, Wayfair, Sunrun, and Moderna are among the stocks that are making significant moves in the stock market.
Johnson & Johnson beats Q1 sales estimates and raises 2023 guidance, while Goldman Sachs misses revenue estimates and takes a $470 million hit tied to the sale of consumer loans in its Marcus unit. Bank of America gains 1.8% after topping Q1 expectations, while Sunrun rises 4.2% after KeyBanc upgrades the stock to overweight. Nvidia gains 2.4% after HSBC upgrades the stock to buy from reduce, and Lockheed Martin beats Q1 expectations and reaffirms full-year guidance. Chubb adds 1.7% on an upgrade from Bank of America to buy from neutral, while Bank of New York Mellon's shares were up 0.8% despite Q1 revenue missing estimates.